Basic HTML Version
Table of Contents
View Full Version
Page 15 - FLIPBOOK
P. 15
Axitinib + Pembrolizumab vs Sunitinib INTERMEDIATE / POOR RISK Powles T, et al. Lancet Oncol. 2020
10
11
12
13
14
15
16
17
18
19
20